| Date Filed | Type | Description |
| 12/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2020 |
4
| Cheruvu Pavan (Principal Executive Officer) has filed a Form 4 on Axovant Gene Therapies Ltd.|
Txns:
| Granted 22,591 shares
@ $0
Paid exercise price by delivering 9,755 shares
@ $3.09, valued at
$30.1k
Disposed/sold 22,591 restricted stock units
@ $0 |
|
| 04/17/2020 |
4
| Cheruvu Pavan (Principal Executive Officer) has filed a Form 4 on Axovant Gene Therapies Ltd.|
Txns:
| Granted 169,100 options to buy
@ $3.45, valued at
$583.4k
Granted 112,700 restricted stock units
@ $0 |
|
| 09/24/2019 |
4
| Cheruvu Pavan (Principal Executive Officer) has filed a Form 4 on Axovant Gene Therapies Ltd.|
Txns:
| Granted 45,181 restricted stock units
@ $0 |
|
| 06/17/2019 |
4
| Cheruvu Pavan (CEO) has filed a Form 4 on Axovant Gene Therapies Ltd.|
Txns:
| Bought 7,500 shares
@ $5.21, valued at
$39.1k
|
|
| 04/17/2019 |
4
| Cheruvu Pavan (CEO) has filed a Form 4 on Axovant Sciences Ltd.|
Txns:
| Granted 1,596,000 options to buy
@ $1.06, valued at
$1.7M
|
|
| 02/15/2018 |
4
| Cheruvu Pavan (CEO) has filed a Form 4 on Axovant Sciences Ltd.|
Txns:
| Granted 1,940,185 options to buy
@ $1.81, valued at
$3.5M
|
|
| 02/15/2018 |
3
| Cheruvu Pavan (CEO) has filed a Form 3 on Axovant Sciences Ltd. |